Clinical experience with a new nasal decongestant.
D004194:Disease; D006801:Humans; D009296:Nasal Cavity; D014663:Nasal Decongestants; D009668:Nose Diseases; D010254:Paranasal Sinus Diseases; D013565:Sympatholytics / Q000627:therapeutic use*
D014663:Nasal Decongestants; D013565:Sympatholytics
NASAL CAVITY/diseases; SYMPATHOLYTICS/therapeutic use